XML 36 R25.htm IDEA: XBRL DOCUMENT v3.25.1
Warrants (Tables)
3 Months Ended
Mar. 31, 2025
Summary of Activity Related to Series A and B Warrants

A summary of activity related to warrants, classified within stockholders’ equity (deficit) for the years presented is as follows:

 

   Shares  

Weighted Average

Exercise Price

  

Weighted Average

Remaining Contractual Term

 
Outstanding as of December 31, 2024   317,664   $4.96    2.60 
Issued – February 7, 2025   450,390    1.20*    
Issued – March 17, 2025   415,420    1.20     
Outstanding as of March 31, 2025   1,183,474    1.72*   2.76 
Exercisable as of March 31, 2025   1,183,474   $1.72*   2.76 

 

* Reflects the exercise price after the March 2025 Down Round Trigger on March 17, 2025 as described above.
Series A and B Warrant [Member]  
Summary of Activity Related to Series A and B Warrants

A summary of activity related to the Series A and B warrants, classified as liabilities, for the three months ended March 31, 2025 is as follows:

  

   Shares  

Weighted Average

Exercise Price

  

Weighted Average

Remaining Contractual Term

 
Outstanding as of December 31, 2024   4,628,312   $1.9445    4.75 
Issued – March 2025 Down Round Trigger   2,582,234    1.2036     
Series B Exercised   (267,849)   1.9445     
Outstanding as of March 31, 2025   6,942,697    1.2036*   4.50 
Exercisable as of March 31, 2025   6,942,697   $1.2036*   4.50 

 

* Reflects the exercise price after the March 2025 Down Round Trigger on March 17, 2025 as described above.